Extended half-life factor IX prophylaxis up to every 21 days in hemophilia B: a longitudinal analysis of the efficacy and safety in selected adult patients
- Resource Type
- Article
- Source
- In
Research and Practice in Thrombosis and Haemostasis May 2023 7(4) - Subject
- Language
- ISSN
- 2475-0379